Objective To explore prescription and syndrome law of TCM in the treatment of non-alcoholic fatty liver disease(NAFLD);To provide reference for clinical medication.Methods The relevant literature on the treatment of NAFLD with TCM was retrieved from CNKI,VIP,Wanfang Data and CBM from the establishment of the databases to October 31,2023.Excel 2019,Lantern 5.0 and SPSS Modeler 18.0 software were used to analyze the latent structure model,association rules and frequency statistics of high-frequency drugs(≥3%)to explore the prescription and syndrome law of TCM in the treatment of NAFLD.Results A total of 453 prescriptions were included,involving 260 kinds of Chinese materia medica,with a cumulative frequency of 4 910 times.The high-frequency drugs were Crataegi Fructus,Salviea Miltiorrhizae Radix et Rhizoma,Alismatis Rhizoma,Bupleuri Radix,Poria and Atractylodis Macrocephalae Rhizoma,etc.The efficacy categories were mainly tonic medicine,diuretic dampness medicine,blood circulation-activating and stasis-resolving medicine,heat-clearing medicine and qi-regulating medicine.The latent structure model obtained 12 latent variables,24 latent classes,and 7 comprehensive clustering models.The commonly used prescriptions were Erchen Decoction,Yinchenhao Decoction,Danggui Shaoyao Powder,Sini Powder,Sijunzi Decoction,Weiling Decoction,Zhuyu Decoction and Dihuang Decoction categorized formula.Conclusion NAFLD is the syndrome of deficiency in root and excess in superficiality.Spleen deficiency is the root cause,phlegm,dampness,heat and blood stasis are the symptoms.In clinical practice,it is mainly based on tonifying qi and spleen,cooperating with the methods of resolving phlegm,eliminating dampness,clearing heat and activating blood circulation.

Objective:To investigate the short-term efficacy and safety of three dimensional (3D) brachytherapy with 192Ir under computed tomography (CT)-guidance in patients with locally advanced cervical carcinoma. Methods:A total of 82 patients with locally advanced cervical carcinoma,who admitted to the Department of Tumor Radiotherapy of the First Affiliated Hospital of Xi 'an Jiaotong University from October 2022 to October 2023,were selected,and they were divided into observation group and control group according to random number table method,with 41 cases in each group. The observation group received 3D brachytherapy with 192Ir under computed tomography (CT)-guidance,and control group received routine two-dimensional (2D) brachytherapy. The short-term efficacy,serum tumor markers,treatment safety and quality of life of the two groups were compared. Results:In observation group,the total effective rate was 97.56％,which was significantly higher than 80.49％ in control group (x2=6.116,P<0.05). The levels of glucose chain antigen 125 (CA125) and squamous cell carcinoma (SCC) antigen of serum tumor markers after treatment of observation group were significantly lower than those of control group (t=11.352,5.507,P<0.05),respectively. The incidences of radiation proctitis and radiation cystitis of observation group were respectively 7.32％ and 4.88％,which were significantly lower than 24.39％ and 21.95％ of control group (x2=4.479,5.143,P<0.05),respectively. After treatment,the scores of functional assessment of cancer therapy-cervix (FACT-Cx) scale (physiological status,social/family status,emotional status,functional status and additional concerns) of observation group were significantly higher than those of control group,and the differences of them between two groups were significantly (t=6.150,7426,9.341,10.029,8.623,P<0.05),respectively. Conclusion:3D brachytherapy with 192Ir under CT-guidance can achieve favorable short-term efficacy and higher safety on patients with locally advanced cervical carcinoma,which is helpful to further improve the quality of life of patients.

Objective:To investigate the short-term efficacy and safety of three dimensional (3D) brachytherapy with 192Ir under computed tomography (CT)-guidance in patients with locally advanced cervical carcinoma. Methods:A total of 82 patients with locally advanced cervical carcinoma,who admitted to the Department of Tumor Radiotherapy of the First Affiliated Hospital of Xi 'an Jiaotong University from October 2022 to October 2023,were selected,and they were divided into observation group and control group according to random number table method,with 41 cases in each group. The observation group received 3D brachytherapy with 192Ir under computed tomography (CT)-guidance,and control group received routine two-dimensional (2D) brachytherapy. The short-term efficacy,serum tumor markers,treatment safety and quality of life of the two groups were compared. Results:In observation group,the total effective rate was 97.56％,which was significantly higher than 80.49％ in control group (x2=6.116,P<0.05). The levels of glucose chain antigen 125 (CA125) and squamous cell carcinoma (SCC) antigen of serum tumor markers after treatment of observation group were significantly lower than those of control group (t=11.352,5.507,P<0.05),respectively. The incidences of radiation proctitis and radiation cystitis of observation group were respectively 7.32％ and 4.88％,which were significantly lower than 24.39％ and 21.95％ of control group (x2=4.479,5.143,P<0.05),respectively. After treatment,the scores of functional assessment of cancer therapy-cervix (FACT-Cx) scale (physiological status,social/family status,emotional status,functional status and additional concerns) of observation group were significantly higher than those of control group,and the differences of them between two groups were significantly (t=6.150,7426,9.341,10.029,8.623,P<0.05),respectively. Conclusion:3D brachytherapy with 192Ir under CT-guidance can achieve favorable short-term efficacy and higher safety on patients with locally advanced cervical carcinoma,which is helpful to further improve the quality of life of patients.

【Objective】 To evaluate the therapeutic value of radiotherapy for ovarian metastasis from small cell lung cancer. 【Methods】 Two patients with ovarian metastasis from small cell lung cancer were recruited, and the value of radiotherapy in the system treatment strategies was analyzed combined with literature reports. 【Results】 The two patients both benefited from local radiotherapy plus system treatment. One was still in complete remission, and compared to that reported in the literature, the local PFS improved to 21 months. 【Conclusion】 Although the prognosis of small cell lung cancer with ovarian metastasis is still poor, radiotherapy might be one of the systematic treatment strategies for improving the survival time of these patients.

The previous pharmacokinetic methods can be only limited to drug analysis in vitro, which provide less information on the distribution and metabolismof drugs, and limit the interpretation and assessment of pharmacokinetics, the determination of metabolic principles, and evaluation of treatment effect. The objective of the study was to investigate the pharmacokinetic characteristics of gene recombination angiogenesis inhibitor Kringle 5 in vivo. The SPECT/CT and specific 131I-Kringle 5 marked by Iodogen method were both applied to explore the pharmacokinetic characteristics of 131I-Kringle 5 in vivo, and to investigate the dynamic distributions of 131I-Kringle 5 in target organs. Labeling recombinant angio-genesis inhibitor Kringle 5 using 131I with longer half-life and imaging in vivo using SPECT instead of PET, could overcome the limitations of previous methods. When the doses of 131I-Kringle 5 were 10.0, 7.5 and 5.0 g/kg, respectively, the two-compartment open models can be determined within all the metabolic process in vivo. There were no significant differences in t1/2α, t1/2β, apparent volume of distribution and CL between those three levels. The ratio of AUC(0 ? 1) among three different groups of 10.0, 7.5 and 5.0 g/kg was 2.56:1.44:1.0, which was close to the ratio (2:1.5:1.0). It could be clear that in the range of 5.0–10.0 g/kg, Kringle 5 was characterized by the first-order pharmacokinetics. Approximately 30 min after 131I-Kringle 5 was injected, 131I-Kringle 5 could be observed to concentrate in the heart, kidneys, liver and other organs by means of planar imaging and tomography. After 1 h of being injected, more radionuclide retained in the bladder, but not in intestinal. It could be concluded that 131I-Kringle 5 is mainly excreted through the kidneys. About 2 h after the injection of 131I-Kringle 5, the radionuclide in the heart, kidneys, liver and other organs was gradually reduced, while more radionuclide was concentrated in the bladder. The radionuclide was completely metabolized within 24 h, and the distribution of radioactivity in rats was similar to normal levels. In our study, the specific marker 131I-Kringle 5 and SPECT/CT were suc-cessfully used to explore pharmacokinetic characteristics of Kringle 5 in rats. The study could provide a new evaluation platform of the specific, in vivo and real-time functional imaging and pharmacokinetics for the clinical application of 131I-Kringle 5.